2024 annual financial data

DiaMedica Therapeutics 2024 Net margin

DiaMedica Therapeutics 2024 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -26,681,000 USD and net income was -24,444,000 USD.
Operating cash flow was -22,076,000 USD.

Get free DiaMedica Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-26,681,000 USD
Net income
-24,444,000 USD
Operating cash flow
-22,076,000 USD